PRORP3 Antibody

What is PRORP3 and what is its biological function?

PRORP3 (Protein-Only RNase P 3) is a nuclear-localized protein that functions as a single-subunit protein-only ribonuclease P enzyme in plants. It belongs to the PPR (Pentatricopeptide Repeat) protein family and plays an essential role in tRNA processing by cleaving the 5' leader sequences from precursor tRNAs. PRORP3 works redundantly with PRORP2 in plant nuclei, and both proteins are capable of performing canonical RNase P activity without requiring an RNA component, unlike the traditional ribonucleoprotein RNase P complexes . The functional characterization of PRORP3 has revealed that it is essential for plant viability, as demonstrated by the finding that double mutants of PRORP2 and PRORP3 are lethal .

How does PRORP3 differ from other PRORP family members?

PRORP family members share functional similarities but differ in their subcellular localization and specific roles. While PRORP1 is typically localized in mitochondria and chloroplasts in plants, PRORP2 and PRORP3 are nuclear-localized . Despite having redundant functions in the nucleus, genetic studies have revealed that individual knockouts of either PRORP2 or PRORP3 do not show lethality or macroscopic phenotypes, but double mutants cannot be obtained, indicating their essential combined function . Human PRORP (also known as MRPP3 or KIAA0391) functions in mitochondria, has 583 amino acid residues with a mass of 67.3 kDa, and has been associated with Combined oxidative phosphorylation deficiency .

What are the primary applications for PRORP3 antibodies in research?

PRORP3 antibodies are valuable tools for several experimental applications:

• Western Blot (WB): Frequently used to detect and quantify PRORP3 protein expression in various tissues or under different experimental conditions .

• Immunofluorescence (IF) and Immunocytochemistry (ICC): Used to visualize the subcellular localization of PRORP3, particularly its nuclear localization .

• Immunohistochemistry (IHC): Employed to detect PRORP3 expression patterns in tissue sections .

• Protein-protein interaction studies: Can be used in co-immunoprecipitation experiments to identify interaction partners of PRORP3.

• Chromatin immunoprecipitation (ChIP): Though less common, may be used if investigating potential DNA associations.

These applications enable researchers to characterize PRORP3 expression, localization, and function in various experimental contexts.

How should I design a multicolor flow cytometry experiment involving PRORP3 antibody?

When designing a multicolor flow cytometry experiment including PRORP3 antibody, consider the following methodological approach:

• Fluorochrome selection: Choose fluorochromes based on PRORP3's expression level. Since PRORP3 is typically expressed at moderate levels, select fluorochromes of appropriate brightness. For highly expressed proteins, less bright fluorochromes like Pacific Blue can be used, while lower expression requires brighter fluorochromes like PE or APC .

• Implement Fluorescence Minus One (FMO) controls: These are essential for accurate gating and interpretation. For a four-color panel including PRORP3, you would need:

  • All antibodies except PRORP3

  • Complete panel including PRORP3
    This approach helps determine the boundary between positive and negative populations .

• Consider compensation requirements: Use single-color compensation beads for each fluorochrome to correct for spectral overlap. Ensure the positive bead population signal is comparable to or higher than expected cellular signals .

• Include appropriate isotype controls: These are particularly important for activation markers. Ensure the isotype control has the same fluorochrome/protein (F/P) ratio as your PRORP3 antibody, preferably from the same manufacturer .

• Block non-specific binding: Pre-incubate samples with blocking antibodies without fluorescent conjugates to minimize background .

What are common issues with PRORP3 antibody specificity and how can I address them?

Several challenges can affect PRORP3 antibody specificity:

• Cross-reactivity with other PRORP family members: Due to sequence homology between PRORP2 and PRORP3, antibodies may recognize both proteins. To address this:

  • Use knockout or knockdown controls to verify specificity

  • Consider peptide competition assays to confirm binding specificity

  • Select antibodies raised against unique epitopes of PRORP3

• Isoform detection variability: With up to 4 different isoforms reported for PRORP proteins , confirm which isoforms your antibody recognizes by:

  • Checking the immunogen sequence against known isoforms

  • Running samples with known isoform expression patterns

  • Using recombinant protein standards representing different isoforms

• Non-specific background: Minimize by:

  • Optimizing antibody concentration through titration experiments

  • Including appropriate blocking agents in your protocol

  • Increasing washing steps and duration

• False positives in closely related species: When working with orthologs in mouse, rat, bovine, frog, zebrafish, chimpanzee, or chicken , validate antibody cross-reactivity through:

  • Western blot comparison with species-specific positive controls

  • Sequence alignment analysis of the immunogen region across species

How can I optimize Western blot protocols for PRORP3 antibody?

For optimal Western blot results with PRORP3 antibody:

• Sample preparation:

  • For nuclear-localized PRORP3, use nuclear extraction protocols rather than whole cell lysates

  • Include protease inhibitors to prevent degradation

  • Denature samples at 95°C for 5 minutes in reducing sample buffer

• Gel selection and transfer:

  • Use 8-10% SDS-PAGE gels for optimal resolution of the ~67.3 kDa PRORP3 protein

  • For transfer, use PVDF membranes with pore size 0.45 μm

  • Transfer at 100V for 60-90 minutes in 10-20% methanol transfer buffer

• Antibody incubation:

  • Block membranes with 5% non-fat dry milk or BSA in TBST for 1 hour

  • Determine optimal primary antibody dilution (typically 1:500 to 1:2000) through titration

  • Incubate with primary antibody overnight at 4°C

  • Use HRP-conjugated secondary antibodies at 1:5000 to 1:10000 dilution

• Detection optimization:

  • For low abundance, use enhanced chemiluminescence (ECL) substrates with higher sensitivity

  • Optimize exposure times based on signal intensity

  • Consider using fluorescently-labeled secondary antibodies for more quantitative analysis

How can I use PRORP3 antibodies to study its role in tRNA processing mechanisms?

To investigate PRORP3's role in tRNA processing:

• In vitro cleavage assays:

  • Generate transcripts representing precursor tRNAs (similar to tRNA Asp(GUC) and tRNA Gln(CUG) used in published work)

  • Incubate with immunoprecipitated PRORP3 under appropriate buffer conditions

  • Analyze cleavage products using gel electrophoresis

  • Confirm precise cleavage sites through circular RT-PCR cloning and sequencing

• Catalytic mutant studies:

  • Create catalytic mutants by introducing aspartate-to-alanine point mutations in the catalytic domain

  • Compare wild-type and mutant PRORP3 activity in cleavage assays

  • This helps identify critical residues for enzymatic function

• Substrate specificity analysis:

  • Test PRORP3 activity on various tRNA precursors

  • Compare processing efficiency between different substrates

  • Analyze structural features that may influence recognition

• Co-immunoprecipitation followed by RNA sequencing:

  • Immunoprecipitate PRORP3 from cellular extracts

  • Sequence associated RNAs to identify in vivo substrates

  • Compare with PRORP2-associated RNAs to detect functional overlaps and differences

What are the considerations for using PRORP3 antibodies in protein-protein interaction studies?

When investigating PRORP3 protein interactions:

• Co-immunoprecipitation (Co-IP) optimization:

  • Choose lysis buffers that preserve protein-protein interactions (avoid harsh detergents)

  • Cross-linking may be necessary for transient interactions

  • Include appropriate negative controls (IgG, unrelated antibody)

  • Validate interactions through reciprocal Co-IP

• Proximity ligation assay (PLA) considerations:

  • Requires two antibodies raised in different species

  • One targeting PRORP3 and another targeting the potential interaction partner

  • Optimizes fixation and permeabilization for nuclear proteins

  • Includes appropriate negative controls to rule out non-specific signals

• Bimolecular Fluorescence Complementation (BiFC):

  • May require epitope-tagged PRORP3 if direct antibodies interfere with interactions

  • Consider the orientation of fusion proteins to avoid steric hindrance

  • Include appropriate controls for spontaneous complementation

• Analysis of interaction dynamics:

  • Consider time-course experiments after cellular treatments

  • Investigate interaction changes during different cell cycle phases

  • Examine effects of RNA depletion on protein interactions

How do I interpret contradicting results between different detection methods using PRORP3 antibodies?

When faced with contradicting results:

• Methodological considerations:

  • Different techniques have inherent limitations: Western blot detects denatured proteins, while IP maintains native conformation

  • ICC/IF detects proteins in fixed cellular contexts that may affect epitope accessibility

  • Each method may detect different pools of PRORP3 (free vs. complexed)

• Systematic validation approach:

  • Verify antibody specificity through knockout/knockdown controls in each method

  • Use multiple antibodies targeting different epitopes of PRORP3

  • Complement antibody-based methods with tagged PRORP3 constructs

• Technical troubleshooting:

  • For Western blot discrepancies, check transfer efficiency and membrane cutting

  • For ICC/IF, evaluate fixation and permeabilization effects on epitope accessibility

  • For IP, assess buffer conditions that might disrupt protein complexes

• Biological interpretation:

  • Consider post-translational modifications that might affect antibody recognition

  • Evaluate potential tissue-specific isoform expression

  • Assess subcellular compartmentalization that might explain apparent discrepancies

How can I use PRORP3 antibodies in combination with other methodologies to comprehensively study its function?

For comprehensive functional analysis:

• Combine antibody-based detection with CRISPR/Cas9 gene editing:

  • Generate PRORP3 knockout or knock-in cell lines

  • Use antibodies to verify knockout efficiency

  • Perform rescue experiments with wild-type or mutant PRORP3

• Integrate immunoprecipitation with mass spectrometry:

  • Use PRORP3 antibodies for IP followed by mass spectrometry

  • Identify novel interaction partners

  • Characterize post-translational modifications on PRORP3

• Complement with RNA-based methods:

  • After PRORP3 depletion, perform RNA-seq to identify affected transcripts

  • Use CLIP-seq (Cross-linking immunoprecipitation) with PRORP3 antibodies to identify directly bound RNAs

  • Perform structure-function analysis through mutagenesis of identified domains

• Evolutionary comparative studies:

  • Use antibodies recognizing conserved epitopes to study PRORP3 orthologs

  • Compare functional conservation across mouse, rat, bovine, frog, zebrafish, chimpanzee, and chicken

  • Analyze species-specific differences in localization or interaction partners

How can PRORP3 antibodies contribute to understanding disease mechanisms?

PRORP proteins have been implicated in disease mechanisms:

• Investigation of mitochondrial diseases:

  • Human PRORP (MRPP3) has been associated with Combined oxidative phosphorylation deficiency (COXPD54)

  • Antibodies can help analyze expression patterns in patient samples

  • Quantitative comparison between healthy and diseased tissues can reveal alterations

• Potential biomarker applications:

  • Similar to other protein markers identified in studies like the ANCA-associated vasculitis research

  • PRORP3 antibodies could help identify alterations in expression patterns preceding symptom onset

  • Analysis of PRORP3 in patient cohorts might reveal associations with specific pathologies

• Functional studies in disease models:

  • Use antibodies to track PRORP3 expression and localization in disease-relevant cell types

  • Analyze potential mislocalization or altered expression in pathological conditions

  • Investigate effects of disease-causing mutations on PRORP3 function

• Therapeutic target validation:

  • Antibodies can help validate PRORP3 as a potential therapeutic target

  • Analyze effects of pharmacological interventions on PRORP3 levels or activity

  • Screen for compounds affecting PRORP3 function or expression

What experimental design considerations are important when studying PRORP3 in different model organisms?

When working with PRORP3 across model organisms:

• Antibody cross-reactivity verification:

  • Test PRORP3 antibodies on samples from target species

  • Perform Western blot with recombinant proteins or tissue lysates from relevant species

  • Consider raising species-specific antibodies if cross-reactivity is insufficient

• Genetic manipulation strategies:

  • In plants, consider the functional redundancy between PRORP2 and PRORP3

  • Design knockout/knockdown strategies accounting for potential compensatory mechanisms

  • For lethal phenotypes, use conditional knockout systems

• Evolutionary considerations:

  • PRORP gene orthologs have been reported in mouse, rat, bovine, frog, zebrafish, chimpanzee, and chicken species

  • Compare sequence conservation in the epitope regions recognized by your antibody

  • Consider functional conservation versus divergence when interpreting results

• Methodological adaptations:

  • Adjust fixation protocols for immunohistochemistry based on tissue characteristics

  • Optimize extraction buffers for different tissue types

  • Consider species-specific secondary antibodies to minimize background